REFRACTORY LARGE B-CELL LYMPHOMA
Clinical trials for REFRACTORY LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug offers hope for lymphoma patients who Can't get transplants
Disease control Recruiting nowThis study tests a drug called epcoritamab in people with large B-cell lymphoma that has come back or not responded to treatment. Participants are those who cannot have a stem cell transplant. The goal is to see if the drug can control the cancer and improve survival without the …
Matched conditions: REFRACTORY LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New CAR-T therapy aims to control aggressive blood cancer
Disease control Recruiting nowThis study tests a new treatment called TC011, which uses a patient's own immune cells (CAR-T cells) to fight a type of blood cancer called large B-cell lymphoma. The trial is for adults whose cancer has come back or not responded to at least two prior treatments. The goal is to …
Matched conditions: REFRACTORY LARGE B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC